black box warning glp 1 glp-1 Semaglutide & weight loss – Zoë Harcombe Health Canada warns about fake

You should not take a GLP-1 drug if you have severe gastrointestinal conditions like inflammatory bowel disease (IBD) or gastroparesis or a personal or family history of multiple endocrine neoplasia 2A, multiple endocrine neoplasia 2B, medullary thyroid cancer, or pancreatitis

Reference: Lhteenvuo M, Tiihonen J, Solismaa A, Tanskanen A, Mittendorfer-Rutz E, Taipale H

That slowing isnt incidentalits the drug doing exactly what it was designed to do, because GLP-1 is the signal that makes it happen

Randomized clinical trial of quick-release bromocriptine among patients with type 2 diabetes on overall safety and cardiovascular outcomes

These indirect effects highlight the need for enhanced oral hygiene and dental monitoring for users